Providers Testify at the 2019 SBA Regulatory Fairness Hearing

Published in Member Communities on August 28, 2019

SBA

In August, the Small Business Administration (SBA) held a Regulatory Fairness Hearing to receive feedback from small business owners about the regulatory environment. Stakeholders that testified on behalf of the DME, CRT, and women’s health industries included Georgie Blackburn of Blackburn’s, John Letizia of Laurel Medical Solutions, Jasmine Jones of Cherry Blossom Intimates, and Nikki Jensen of Essentially Women/VGM.

Georgie Blackburn began by illuminating what is happening to small businesses contracted to provide durable medical equipment to Medicaid recipients under the CMS authorized state managed care model. She made it known that these are concerns not only in her state, but all across the country. John Letizia addressed Medicare reimbursement for CRT accessories saying that, as an independent supplier, his company prides itself on the service that they provide to their customers. However, CMS’s flawed pricing policy is affecting their ability to provide service to their power wheelchair customers.

Tom Powers of VGM also attended the event, and he reports that the SBA Hearing was a great opportunity to get the industry’s message across about the business challenges and barriers preventing access to care caused by regulations. He also said that H.R. 2771, H.R. 2293, H.R. 2408, and H.R. 1370 were well received during these presentations to the panel of National Ombudsman.

A special thanks to all of the medical equipment suppliers who testified or attended in support of the industry. To read more about the hearing, click here.

From Our Experts

Why Signature Issues Continue to Trip Up DME Suppliers thumbnail Why Signature Issues Continue to Trip Up DME Suppliers Discover why signature-related documentation issues continue to create claim denials, audit risks, and reimbursement challenges for DME suppliers. The Fortune Is in the Follow-Up thumbnail The Fortune Is in the Follow-Up The fortune is in the follow-up. Not because follow-up is exciting. Most of the time it's not. In fact, it's often the least glamorous part of the job. But that's exactly why it creates so much value. Most people are willing to start something. Fewer people are willing to stick with it until it's finished. Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers thumbnail Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers Discover how to optimize your sleep therapy business with scalable workflows, faster therapy starts, improved adherence, and predictable revenue growth. Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers thumbnail Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers Discover how to optimize your sleep therapy business with scalable workflows, faster therapy starts, improved adherence, and predictable revenue growth. Adaptability Is Key to Long-Term Success in HME thumbnail Adaptability Is Key to Long-Term Success in HME Industry leader Lisa Wells shares insights on growth, payer relationships, and AI and why providers must adapt to succeed. ROI of D.C.: Understanding the Impact of CRT and HME Advocacy thumbnail ROI of D.C.: Understanding the Impact of CRT and HME Advocacy Legislation influences patient care. Learn about the importance of voting records in sustaining the CRT and HME industries. The Future of CRT Depends on Stronger Grassroots Advocacy Now thumbnail The Future of CRT Depends on Stronger Grassroots Advocacy Now The future of CRT access depends on broader industry and grassroots advocacy to defend reimbursement, influence policy, and improve patient access to care. Unlearning Is Harder Than Learning—Especially in Billing & Reimbursement thumbnail Unlearning Is Harder Than Learning—Especially in Billing & Reimbursement Outdated billing & reimbursement habits can increase audit risk. Learn why DME suppliers must unlearn assumptions, validate guidance, & strengthen compliance.